Beacon Pointe Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
19,467
-48
| -0.2% | -$25.2K | 0.11% | 175 |
|
|
2025
Q1 | $12.4M | Sell |
19,515
-161
| -0.8% | -$102K | 0.14% | 148 |
|
|
2024
Q4 | $14M | Sell |
19,676
-425
| -2% | -$303K | 0.16% | 136 |
|
|
2024
Q3 | $21.1M | Sell |
20,101
-2,169
| -10% | -$2.28M | 0.24% | 100 |
|
|
2024
Q2 | $23.4M | Sell |
22,270
-330
| -1% | -$347K | 0.28% | 77 |
|
|
2024
Q1 | $21.8M | Sell |
22,600
-186
| -0.8% | -$179K | 0.24% | 90 |
|
|
2023
Q4 | $20M | Sell |
22,786
-1,045
| -4% | -$918K | 0.24% | 102 |
|
|
2023
Q3 | $19.6M | Buy |
23,831
+1,259
| +6% | +$1.04M | 0.24% | 100 |
|
|
2023
Q2 | $16.2M | Sell |
22,572
-2,207
| -9% | -$1.59M | 0.26% | 91 |
|
|
2023
Q1 | $20.4M | Sell |
24,779
-7,144
| -22% | -$5.87M | 0.35% | 74 |
|
|
2022
Q4 | $23M | Buy |
31,923
+4,210
| +15% | +$3.04M | 0.45% | 54 |
|
|
2022
Q3 | $19.1M | Sell |
27,713
-338
| -1% | -$233K | 0.43% | 57 |
|
|
2022
Q2 | $16.6M | Sell |
28,051
-499
| -2% | -$295K | 0.35% | 71 |
|
|
2022
Q1 | $19.9M | Buy |
28,550
+3,603
| +14% | +$2.52M | 0.27% | 90 |
|
|
2021
Q4 | $15.8M | Sell |
24,947
-4,104
| -14% | -$2.59M | 0.41% | 58 |
|
|
2021
Q3 | $17.6M | Buy |
29,051
+21,898
| +306% | +$13.3M | 0.43% | 56 |
|
|
2021
Q2 | $4M | Buy |
+7,153
| New | +$4M | 0.14% | 144 |
|